CRMDCorMedix Inc.

$518M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$35,266+367.0% YoY

Gross Profit

$14,13840.1% margin

Operating Income

-$6M-15701.7% margin

Net Income

-$696,158-1974.0% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

-78.5%

Cash Flow

Operating Cash Flow

$164,455

Free Cash Flow

$160,949

Stock-Based Comp.

$606,331

Balance Sheet

Total Assets

$28M

Total Liabilities

$11M

Stockholders' Equity

-$185M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35,266	$7,551	+367.0%
Gross Profit	$14,138	-$26,112	+154.1%
Operating Income	-$6M	-$9M	+35.4%
Net Income	-$696,158	-$9M	+91.9%

CRMD Q2 2019 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena